Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
It’s not yet known how many people have gotten sick in the Texas measles outbreak, but there are at least 215 confirmed cases since late January.
Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...
A clinical trial suggests Lenacapavir, a yearly injection, could revolutionise HIV prevention by offering long-term protection, simplifying adherence, and expanding access to at-risk populations.
Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.